Organic Natural Cosmetics

Natick, MA, and Cleburne, TX (PRWEB) October 28, 2014

AmericanBio, Inc. and Boval BioSolutions announced the formation of a joint venture involving the continuous development and marketing of Bovine Serum Albumin RNase / DNase Free products. These two powerful life science brands have partnered, and with this alliance it should allow them to exclusively bring to market products for growing life science applications, both within the private business sectors and academia research channels. Terms of this agreement are confidential.

The complimentary new venture will combine Boval’s deep expertise in Bovine Serum development and AmericanBio’s expertise in providing Ultra Pure Molecular tools. While it also aligns well with AmericanBio’s long history of designing customized products for biotech, molecular, and academic organizations, this venture will demonstrate what is possible when leading companies with complementary capabilities work together to enhance the life science landscape.

AmericanBio CEO, Wayne Gagnon explained that “it has always been about delivering high-quality products and services, we have a reputation in the industry that is second to none, and we feel that our complimentary venture with Boval BioScience will yield exceptional results for both companies, as well as our mutual customers.”

Cody Yarborough President of Boval BioScience, offered similar sentiments: “It’s critical that that our products are readily available to the end user, and we feel that AmericanBio is the perfect partner to ensure that customers have the necessary accessibility to RNase and DNase Free BSA.”

About AmericanBio, Inc.

AmericanBio has been a market leader within the life science industry for more than thirty-seven years, always standing by our inherent mission of quality, service, and value. We are the premier provider of Ultra Pure, ACS, USP, CLIA Grade chemicals and custom reagent manufacturing services. Our products are utilized for nucleic acid detection and labeling, electrophoresis, extraction and purification, hybridization and synthesis. The Company’s mission is to provide high-quality, cost effective solutions that support the growth of its customers through exceptional and flexible customer service. AmericanBio is ISO-13485, ISO-9001 and cGMP certified. For more information, visit http://www.americanbio.com.

About Boval BioSolutions, LLC

Boval has been a producer of high purity Serum Albumin since 1978 and, with over 35 years of manufacturing experience, we are committed to exceed the highest levels of quality and purity that the market has to offer. Our USDA-registered manufacturing plant uses cGMP and HACCP quality programs. Our quality management system is certified to ISO 9001:2008 and ISO 13485:2003. We also have internal chemical, physical and microbiological testing capabilities. Production of Human Albumin Products was added in 2010 as well as extensive cell culture research from animal and non-animal derived proteins. For more information, visit http://www.bovalco.com

Find More USDA Manufacture Press Releases

Paris, France (PRWEB) January 28, 2015

ThermiGyn, a wholly owned subsidiary of ThermiHealth, a world leader in thermistor-regulated energy solutions for medical and aesthetic applications, will announce breakthroughs in non-surgical vaginal rejuvenation at the 17th Annual IMCAS World Conference in Paris on January 30th.

Aging, loss of collagen, and vaginal births can result in vulvolaxity and dryness both internally and externally. Pelvic organ prolapse, tissue stretching, and nerve impairment are known impediments of sexual satisfaction and well-being. Red Alinsod, MD, FACOG, FACS, ACGE will present the findings of a pilot study using the ThermiVa procedure to treat vulvovaginal tissue using temperature controlled radio frequency. Dr. Alinsod is a global leader in the area of temperature controlled RF for the treatment of vulvovaginal laxity, and he is the Chairman of the ThermiGyn Women’s Health Advisory Clinical Board.

In this pilot study, both vulvar laxity and vaginal laxity improved significantly for all patients after the first treatment and continued to improve after the third and final treatment. All participants reported improvement of sexual satisfaction as a result of the treatment. The primary endpoint of vulvovaginal tightening was achieved in all patients, and secondary endpoints of improved vaginal moisture and improved continence was achieved in selected patients with prior conditions. A larger multi-site IRB study has been approved, and participants are currently being selected.

Dr. Alinsod noted, “The potential for a simple and safe temperature controlled RF device to treat vulvovaginal laxity, atrophic vaginitis, mild to moderate stress incontinence, overactive bladder, and orgasmic dysfunctions holds great promise and could be transformational.”

ThermiHealth Technology

ThermiHealth Systems integrate precise thermistor controlled micro-invasive and non-invasive applicators into unique multiuse platforms. The micro-invasive applicators are true surgeons’ tools that provide surgeons a safe and effective instrument. Both the micro-invasive and the non-invasive applicators help the operator insure that specific tissue temperatures are achieved, maintained and monitored during procedures to help ensure safety and maximize results.

The ThermiAesthetics flagship product is the ThermiRF Temperature Controlled Radio Frequency Generator System and is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis, and to create lesions in nervous tissue.

About ThermiHealth

ThermiHealth is a privately held company developing a broad range of uses for thermistor controlled radio frequency technologies and for applications in the medical and aesthetic marketplaces.

ThermiAesthetics, a Division of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for Plastic Surgeons, Facial Plastic Surgeons, Dermatologist, Cosmetic Surgeons and other physicians serving the aesthetic market.

ThermiGyn, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for OB GYNs serving the women’s health marketplace.

ThermiEye, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform, promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for Ophthalmologists, Ocular Plastic Surgeons and other physicians serving the aesthetic market

For more information about ThermiHealth Companies, please visit http://www.thermi.com.

###